Results 251 to 260 of about 3,142,633 (314)
Drug resistance limits treatment success in a subset of lung cancers driven by ROS1 gene alterations. Using patient‐derived cells and computer simulations, we studied three key mutations and how they affect five targeted drugs. The mutations reduced drug effectiveness in different ways by altering protein structure and behavior.
Farhan Ul Haq +8 more
wiley +1 more source
Plasminogen Activator Inhibitor-1 as a Therapeutic Target for Healthy Longevity, Immunosenescence, and Age-Related Disease: Translational Development of the Small-Molecule Inhibitor TM5614. [PDF]
Abdelhakim M, Miyata T.
europepmc +1 more source
BCL9 and BCL9L drive bladder cancer progression by enhancing β‐catenin signaling, promoting proliferation, migration, invasion, and organoid growth. Genetic depletion of BCL9(L) suppresses malignant phenotypes, while pharmacological disruption of the β‐catenin/BCL9(L) complex with ZW4864 inhibits canonical Wnt signaling and tumor‐associated cellular ...
Roland Kotolloshi +11 more
wiley +1 more source
Polymer-Based Scale Inhibition of Calcium Sulfate Using Phosphino-Polycarboxylic Acid: Experimental Evaluation, RSM Modeling, and Process Optimization. [PDF]
Khormali A, Ahmadi S.
europepmc +1 more source
The endogenous cannabinoid system gates plasticity of tonic GABA inhibition. [PDF]
Colangeli R, Conti F.
europepmc +1 more source
CRISPRI‐mediated gene silencing and phenotypic exploration in nontuberculous mycobacteria. In this Research Protocol, we describe approaches to control, monitor, and quantitatively assess CRISPRI‐mediated gene silencing in M. smegmatis and M. abscessus model organisms.
Vanessa Point +7 more
wiley +1 more source
Rewiring mTOR signaling in Alzheimer's disease: emerging mTOR modulators beyond oncology. [PDF]
Lohnes BJ +4 more
europepmc +1 more source

